1-3 of 3
Robert Wild
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

18FDG-PET Predicts Pharmacodynamic Response to OSI-906, a Dual IGF-1R/IR Inhibitor, in Preclinical Mouse Models of Lung Cancer

Free
Eliot T. McKinley, Joseph E. Bugaj, Ping Zhao, Saffet Guleryuz, Christine Mantis, Prafulla C. Gokhale, Robert Wild, H. Charles Manning
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (10): 3332–3340.
https://doi.org/10.1158/1078-0432.CCR-10-2274
Published: 15 May 2011
View articletitled, 18FDG-PET Predicts Pharmacodynamic Response to OSI-906, a Dual IGF-1R/IR Inhibitor, in Preclinical Mouse Models of Lung Cancer
Open the PDF for 18FDG-PET Predicts Pharmacodynamic Response to OSI-906, a Dual IGF-1R/IR Inhibitor, in Preclinical Mouse Models of Lung Cancer in another window
Includes: Supplementary data
Journal Articles

Prediction of Active Drug Plasma Concentrations Achieved in Cancer Patients by Pharmacodynamic Biomarkers Identified from the Geo Human Colon Carcinoma Xenograft Model

Free
Feng R. Luo, Zheng Yang, Huijin Dong, Amy Camuso, Kelly McGlinchey, Krista Fager, Christine Flefleh, David Kan, Ivan Inigo, Stephen Castaneda, Tai W. Wong, Robert A. Kramer, Robert Wild, Francis Y. Lee
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (15): 5558–5565.
https://doi.org/10.1158/1078-0432.CCR-05-0368
Published: 01 August 2005
View articletitled, Prediction of Active Drug Plasma Concentrations Achieved in Cancer Patients by Pharmacodynamic Biomarkers Identified from the Geo Human Colon Carcinoma Xenograft Model
Open the PDF for Prediction of Active Drug Plasma Concentrations Achieved in Cancer Patients by Pharmacodynamic Biomarkers Identified from the Geo Human Colon Carcinoma Xenograft Model in another window
Journal Articles

Therapeutic Synergy of Oral Taxane BMS-275183 and Cetuximab versus Human Tumor Xenografts

Free
William C. Rose, Robert Wild
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (21): 7413–7417.
https://doi.org/10.1158/1078-0432.CCR-04-1045
Published: 08 November 2004
View articletitled, Therapeutic Synergy of Oral Taxane BMS-275183 and Cetuximab versus Human Tumor Xenografts
Open the PDF for Therapeutic Synergy of Oral Taxane BMS-275183 and Cetuximab versus Human Tumor Xenografts in another window